XML 147 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue recognition (Tables)
 9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue The Company's revenues disaggregated by operating segment and major sources for the three and nine months ended September 30, 2024 and 2023 were as follows:
Three Months Ended September 30, 2024Three Months Ended September 30, 2023
USGNon-USG TotalUSGNon-USG Total
Commercial Product sales$— $95.3 $95.3 $0.3 $141.8 $142.1 
MCM Product sales161.8 12.4 174.2 102.7 5.0 107.7 
Bioservices:
Services— 13.9 13.9 — 13.2 13.2 
Leases— 0.4 0.4 — 1.0 1.0 
Total Bioservices$— $14.3 $14.3 $— $14.2 $14.2 
Contracts and grants9.7 0.3 10.0 5.1 1.4 6.5 
Total revenues$171.5 $122.3 $293.8 $108.1 $162.4 $270.5 
Nine Months Ended September 30, 2024Nine Months Ended September 30, 2023
USGNon-USG TotalUSGNon-USG Total
Commercial Product sales$0.4 $333.4 $333.8 $0.6 $385.6 $386.2 
MCM Product sales319.7 73.3 393.0 279.0 30.2 309.2 
Bioservices:
Services (1)
— 96.7 96.7 — 52.2 52.2 
Leases— 0.8 0.8 — 5.5 5.5 
Total Bioservices$— $97.5 $97.5 $— $57.7 $57.7 
Contracts and grants23.7 0.9 24.6 14.6 5.0 19.6 
Total revenues$343.8 $505.1 $848.9 $294.2 $478.5 $772.7 
(1) Bioservices Services revenues for the nine months ended September 30, 2024 include $50.0 million attributable to the Settlement Agreement with Janssen related to the 2022 termination of the Janssen Agreement. The revenue is related to raw materials purchased for the Janssen Agreement which Janssen had not reimbursed. See Note 15, “Litigation” for additional information related to the accounting treatment and settlement of the arbitration with Janssen.
Schedule of Rollforward of Contract Liabilities The following table presents the roll forward of the contract liability balances:
Contract Liabilities
Balance at December 31, 2023$29.9 
Balance at September 30, 2024$10.7 
Revenue recognized in the period from amounts included in contract liability at the beginning of the period:$25.8 
Schedule of Accounts Receivable, Net
Accounts receivable, including unbilled accounts receivable contract assets, consist of the following:
September 30, 2024December 31, 2023
Accounts receivable:
Billed$102.6 $141.8 
Unbilled19.2 51.4 
Allowance for expected credit losses(0.5)(2.2)
Accounts receivable, net$121.3 $191.0